... dimer has been extensively investigated for the diagnosis of venous thromboembolism (VTE) and is used routinely for this indication... dimer has been evaluated for determining the optimal duration of anticoagulation in VTE patients, for diagnosing and monitoring disseminated intravascular coagulation, and as an aid in the identification of medical patients at high risk for VTE ...
... compared them with those from patients without cirrhosis with venous thromboembolism (VTE) (n=160) for up to 4 years... in patients with PVT vs controls AbstractText: The group with VTE and the group with PVT were comparable in age, sex, and time in the therapeutic range, but patients with VTE received VKAs for a longer time period (31.1± months vs ... Portal hypertension, rather than anti-coagulants, could account for the difference in risk of major bleeding between patients with PVT vs patients with VTE Keyword: hemorrhage ...
... in order to reduce the risk of a first venous thromboembolism (VTE) in pregnancy.Design Systematic review and bayesian meta-analysis.Data ... Observational studies that reported on pregnancies without the use of anticoagulants and the outcome of first VTE for women with thrombophilia were eligible for inclusion ... VTE was considered established if it was confirmed by objective means ...
... on peak anti-Xa levels is associated with the venous thromboembolism (VTE) rate after trauma AbstractText: Retrospective review of 950 consecutive adults ... Patients younger than 18 years and those with VTE on admission were excluded, resulting in a study population of ... patients AbstractText: The control group received fixed doses of either heparin sodium, 5000 U 3 times a day, or enoxaparin sodium ...
Cardiovascular Diseases (2) Venous Thromboembolism (2), more mentions
... between recurrence of chronic subdural hematoma and postoperative application of thrombosis prophylaxis AbstractText: Retrospective, consecutive sample of patients undergoing burr-hole ... for chronic subdural hematoma over 3 years AbstractText: Single, academic medical center AbstractText: All patients undergoing surgical evacuation of a chronic ... Out of the 234 analyzed patients, 135 (57.3%) received postoperative thrombosis prophylaxis (low-molecular-weight heparin) applied subcutaneously.
Abstract: Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the treatment of choice for the prevention of atherothrombotic events in ... The availability of different oral P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) has enabled physicians to contemplate switching among therapies because of specific clinical scenarios... Keyword: drug interactions... Keyword: thrombosis.
... ambulance service prior to or during transfer of patients with warfarin-associated major hemorrhage to a tertiary care center for definitive ... retrospective chart review of patients presenting to a large academic medical center... with an International Normalized Ratio (INR) > 1.5 actively treated with warfarin were included... leads to more rapid improvement in INR among patients with warfarin-associated major hemorrhage.
... incidence and natural history of incidentally found and untreated pulmonary embolism (PE) at coronary CT angiography after coronary artery bypass grafting ... All patients received 100 mg of aspirin and 75 mg of clopidogrel after surgery... Twenty of the 22 patients did not receive anticoagulation, and all but one of these patients had complete resolution ... postoperative coronary CT angiography, and most PEs resolve spontaneously without anticoagulation.
AbstractText: Very late scaffold thrombosis (VLScT) occurs more frequently after bioresorbable scaffold (Absorb BVS 1.1 ... The INVEST (Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis) registry is an international consortium of investigators who used OCT ... At the time of VLScT, 83% of patients received aspirin monotherapy and 17% received dual-antiplatelet therapy.
DescriptorName: Aspirin... In the DAPT Study, combined myocardial infarction (MI) or stent thrombosis and moderate/severe bleeding were assessed in enrolled (n = 25 ... bifurcation with side branch ≥2.5 mm, vein bypass graft, or thrombus-containing lesion... complex target lesions had higher rates of MI or stent thrombosis in the first 12 months after PCI (3.9% vs. 2.4 ...
Thrombosis (5), Myocardial Infarction (2), Hemorrhage (1), more mentions
AbstractText: The ENSURE-AF study (NCT 02072434) of anticoagulation for electrical cardioversion in nonvalvular atrial fibrillation (NVAF) showed comparable low rates of bleeding and thromboembolism between the edoxaban and the enoxaparin-warfarin treatment arms ... or concomitant P-glycoprotein inhibitors compared with therapeutically monitored enoxaparin-warfarin in 2,199 NVAF patients undergoing electrical cardioversion.
Cardiovascular Diseases (2) Atrial Fibrillation (2), Thromboembolism (1), more mentions
... contrast under vitamin K antagonist (VKA) agents and novel oral anticoagulants (NOACs), (2) evaluate the rate of LAA thrombus resolution after anticoagulation modification, and (3) determine the predictive factors of LAA thrombi ... was similar under NOACs (2.1%) and VKA agents (2.6%) AbstractText: Thrombus resolution was obtained in 50% of cases following anticoagulation modification.
Cardiovascular Diseases (1) Thrombus (4), Atrial Fibrillation (1), more mentions
In the acute setting, the decision to withhold anticoagulants is based on an individual patient's risk of thrombosis and the severity of the bleeding ... For women who require long-term anticoagulation, the use of levonorgestrel intrauterine system, tranexamic acid (during menstrual ... hormonal contraceptives are effective for controlling HMB; the risk of thrombosis during anticoagulant therapy with these treatments is not well studied, but is ...
... the effect of a recanalisation procedure versus each other or anticoagulant therapy in patients diagnosed with PE... trial characteristics and the reported effects of recanalisation procedures versus anticoagulation AbstractText: For all-cause mortality, there were no significant differences ... in event rates between any of the recanalisation procedures and anticoagulant treatment (full-dose thrombolysis: OR 0.60; 95% CI0.36 to 1.01 ...
Trending in Altmetric
This article is in the top 10% of similar research outputs scored by Altmetric,
a service which tracks the online attention articles have received.
McMaster PLUS Selected
This article has been identified as especially clinically relevant or newsworthy by at least 3
practicing clinicians and of high scientific quality by expert researchers
as a part of the McMaster PLUS article rating service.
... with metallic stents AbstractText: To estimate the incidence of scaffold thrombosis after BVS implantation and compare everolimus-eluting BVSs with everolimus ... a BVS or an EES and reported scaffold or stent thrombosis (main outcome) or other secondary outcomes (such as death, myocardial ... evidence AbstractText: The pooled incidence of definite or probable scaffold thrombosis after BVS implantation was 1.8% (95% CI, 1.5% to 2.2 ...
Thrombosis (6), Myocardial Infarction (2), Coronary Disease (1), more mentions
... lesion revascularization), and the primary safety outcome measure was device thrombosis... Device thrombosis rates through 3 years were also higher with BVS (2.4 ... lesion failure rates (6.1% versus 3.9%; P=0.02) and device thrombosis rates (1.1% versus 0.0%; P <0.0001) were higher with BVS ... associated with increased rates of target lesion failure and device thrombosis between 1 and 3 years and cumulatively through 3 years ...
Thrombosis (4), Ischemia (2), Myocardial Infarction (2), more mentions
... requiring massive transfusion, improper administration and increased risk of venous thromboembolism remain a concern AbstractText: To determine the appropriateness of TXA administration by US military medical personnel based on current Joint Trauma System clinical practice guidelines ... and to determine if TXA administration is associated with venous thromboembolism AbstractText: This cohort study of US military casualties in US ...
Cardiovascular Diseases (5) Venous Thromboembolism (5), more mentions
... L-lactic acid-based bioresorbable vascular scaffold (BVS) provides early drug delivery and mechanical support functions similar to metallic drug-eluting stents (DES), followed by complete bioresorption in approximately 3 ... with BVS (8.6% vs. 5.9%; p = 0.03), as was device thrombosis (2.3% vs. 0.7%; p = 0.01... was an independent predictor of 3-year TLF and scaffold thrombosis AbstractText: In the ABSORB III trial, 3-year adverse event ... were higher with BVS than EES, particularly TVMI and device thrombosis.
Thrombosis (3), Ischemia (1), Myocardial Infarction (1), more mentions
AbstractText: To compare key outcomes after transcatheter arterial embolization (TAE) with conventional surgery for peptic ulcer bleeding when endoscopic intervention fails to achieve hemostasis AbstractText: Mortality in peptic ulcer bleeding remains high, especially in patients who require surgical treatment AbstractText ... Data were taken from well-maintained registries and medical records.